Literature DB >> 8621224

Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study.

M Sakaguchi1, Y Fujii, H Hirabayashi, H E Yoon, Y Komoto, T Oue, T Kusafuka, A Okada, H Matsuda.   

Abstract

Cdk4-mediated phosphorylation of Rb protein is inhibited by p16, a product of a possible tumor suppressor gene. We examined the expression of p16 and Rb protein by means of immunohistochemistry in 61 non-small cell lung cancers and have demonstrated an inverse relationship between the expression of p16 and Rb protein: 28/30 specimens that did not stain for p16 stained for Rb and 21/31 p16-positive specimens did not stain for Rb. Only 1 of the p16-negative specimens had a mutation of exon 2 of the CDKN2 gene. Our results indirectly support the theory that p16 expression is negatively regulated by the functional Rb protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621224     DOI: 10.1002/(SICI)1097-0215(19960208)65:4<442::AID-IJC8>3.0.CO;2-X

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.

Authors:  V G Gorgoulis; E N Koutroumbi; A Kotsinas; P Zacharatos; C Markopoulos; L Giannikos; V Kyriakou; Z Voulgaris; I Gogas; C Kittas
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

2.  p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.

Authors:  G Busatto; Y H Shiao; A R Parenti; R Baffa; A Ruol; M Plebani; M Rugge
Journal:  Mol Pathol       Date:  1998-04

3.  Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Authors:  S E Coupland; N Bechrakis; A Schüler; I Anagnostopoulos; M Hummel; N Bornfeld; H Stein
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

4.  Epstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma.

Authors:  Suhail Al-Salam; Aktham Awwad; Manjusha Sudhadevi; Sayel Daoud; Nico J D Nagelkerke; Antonio Castella; S M Chong; Mouied Alashari
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

5.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

6.  Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions.

Authors:  T Sano; T Oyama; K Kashiwabara; T Fukuda; T Nakajima
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

7.  p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

Authors:  N Murphy; M Ring; A G Killalea; V Uhlmann; M O'Donovan; F Mulcahy; M Turner; E McGuinness; M Griffin; C Martin; O Sheils; J J O'Leary
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

8.  Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer.

Authors:  Takuma Fujii; Miyuki Saito; Takashi Iwata; Nobumaru Hirao; Hiroshi Nishio; Akiko Ohno; Katsumi Tsukazaki; Makio Mukai; Kaori Kameyama; Daisuke Aoki
Journal:  Virchows Arch       Date:  2008-10-21       Impact factor: 4.064

9.  Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection.

Authors:  Eun Ji Nam; Jae Wook Kim; Jong Wook Hong; Hyoung Sun Jang; Sang Yub Lee; Si Young Jang; Dae Woo Lee; Sang Wun Kim; Jae Hoon Kim; Young Tae Kim; Sunghoon Kim; Jong Wook Kim
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

10.  p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens.

Authors:  Iana Lesnikova; Marianne Lidang; Stephen Hamilton-Dutoit; Jørn Koch
Journal:  Diagn Pathol       Date:  2009-07-09       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.